{
    "code": "02023537",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02023537",
    "time": "2020-06-19 03:17:10",
    "許可證字號": "衛署藥輸字第023537號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "111\/08\/28",
    "發證日期": "91\/08\/28",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202353701",
    "中文品名": "複方舒而坦 眼藥水",
    "英文品名": "XALACOM EYE DROPS",
    "適應症": "開放性青光眼及高眼壓症，且對局部β－BLOCKER治療無效時。",
    "劑型": "472點眼液劑",
    "包裝": "100公撮以下塑膠瓶裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "TIMOLOL MALEATE, LATANOPROST",
    "限制項目": "02輸　入 53依本署七七公告事項八得免除國內進行臨床試驗之特殊醫療需要之新藥",
    "申請商名稱": "1504401100  輝瑞大藥廠股份有限公司",
    "申請商地址": "台北市信義路松仁路100號42、43樓",
    "主製造廠": [
        {
            "製造廠名稱": "FBE0011000  PFIZER MANUFACTURING BELGIUM NV",
            "製造廠廠址": "RIJKSWEG 12, 2870, PUURS, BELGIUM",
            "製造廠公司地址": "",
            "製造廠國別": "BELGIUM",
            "製程": ""
        }
    ],
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1216001910",
            "成分名稱": "TIMOLOL MALEATE",
            "含量描述": "",
            "含量": "6.8300000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "9200037500",
            "成分名稱": "LATANOPROST",
            "含量描述": "",
            "含量": "50.0000000000",
            "單位": "MCG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "Xalacom 外觀-104-09-21(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023537&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "02 023537 0001-106-04-25.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023537&Seq=025&Type=9"
        },
        {
            "title": "Xalacom 外盒-104-09-21(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023537&Seq=003&Type=8"
        }
    ]
}